4IP Stock Chart & Stats
$0.01
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range<$0.01 - $0.01
Previous CloseN/A
VolumeN/A
Average Volume (3M)31.00K
Market Cap
€17.32M
Enterprise Value$31.99M
Total Cash (Recent Filing)€2.93M
Total Debt (Recent Filing)€7.23M
Price to Earnings (P/E)―
Beta>-0.01
Next Earnings
Mar 04, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding2,776,410,600
10 Day Avg. Volume31,000
30 Day Avg. Volume31,000
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)2.01
Price to Sales (P/S)1.39
P/FCF Ratio36.12
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthRapid revenue expansion indicates growing business scale and market activity. If maintained, the larger revenue base can support operating investment, improve customer reach, and create a foundation for future margin improvement, even though profitability has not yet become consistent.
Positive Free Cash FlowPositive free cash flow across three fiscal years provides internal funding capacity and reduces near-term reliance on external capital. The FY2026 step-up is particularly supportive because cash remained positive despite a net loss, strengthening financial resilience while the business scales.
Manageable LeverageDebt at roughly half of equity and stable total assets suggest the balance sheet is serviceable rather than highly stretched. This gives Parkway some capacity to manage operations and pursue growth, although rebuilding equity through sustained profits remains important for longer-term flexibility.
Bears Say
Inconsistent ProfitabilityThe return to losses after a prior profit shows that revenue growth has not yet translated into dependable earnings. Material gross-margin compression limits operating leverage and leaves results sensitive to costs, making sustainable profitability a central execution challenge over coming quarters.
Low Cash EfficiencyAlthough free cash flow is positive, modest operating cash flow relative to revenue indicates that sales are not converting into cash as efficiently as they could. Persistent cash inefficiency may restrict reinvestment capacity and reduce the durability of funding support if growth continues.
Declining Equity And Negative ROEFalling equity alongside negative return on equity reflects the impact of FY2026 losses and weak capital productivity. Unless profitability improves, continued erosion of the equity base could reduce financial flexibility and make future growth less efficient to fund.
Parkway Corporate Limited News
4IP FAQ
What was Parkway Corporate Limited’s price range in the past 12 months?
Parkway Corporate Limited lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is Parkway Corporate Limited’s market cap?
Parkway Corporate Limited’s market cap is €17.32M.
When is Parkway Corporate Limited’s upcoming earnings report date?
Parkway Corporate Limited’s upcoming earnings report date is Mar 04, 2027 which is in 141 days.
How were Parkway Corporate Limited’s earnings last quarter?
Parkway Corporate Limited released its earnings results on Sep 29, 2026. The company reported $0 earnings per share for the quarter.
Is Parkway Corporate Limited overvalued?
According to Wall Street analysts Parkway Corporate Limited’s price is currently Undervalued.
Does Parkway Corporate Limited pay dividends?
Parkway Corporate Limited does not currently pay dividends.
What is Parkway Corporate Limited’s EPS estimate?
Parkway Corporate Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Parkway Corporate Limited have?
Parkway Corporate Limited has 2,776,410,600 shares outstanding.
What happened to Parkway Corporate Limited’s price movement after its last earnings report?
Parkway Corporate Limited reported an EPS of $0 in its last earnings report. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Parkway Corporate Limited?
Currently, no hedge funds are holding shares in DE:4IP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Parkway Corporate Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
DE:4IP Sentiment 94%
Sector Average 64%
Sector Average 64%
Insider Transactions
Bought Shares
Worth €15.7K over
the Last 3 Months
the Last 3 Months
Fundamentals
Return on Equity
-2.85%
Trailing 12-Months
Asset Growth
6.93%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Parkway Corporate Limited
Parkway Corporate Limited is an Australian cleantech enterprise focused on delivering comprehensive water treatment solutions. The company operates through three distinct segments: Parkway Process Solutions, Parkway Process Technologies, and Parkway Ventures. Through its technology and solutions divisions, Parkway supplies a broad spectrum of products. These encompass specialized analytical instruments for assessing water treatment parameters, a full range of laboratory equipment including glassware and consumables such as syringes and test tubes, and diverse water treatment systems. The company also provides an extensive selection of pumps, from chemical dosing to high-pressure and submersible models, alongside their requisite parts and accessories. Additional offerings include advanced instrumentation and controllers for monitoring, measuring, and automating water treatment processes; piping, hoses, and fittings; various valves and solenoids; filtration and membrane technologies; and robust industrial tanks designed for high-value water treatment applications. Furthermore, Parkway provides an array of water treatment chemicals and advanced disinfection products utilizing methods like chemical disinfection, chlorination, ozone, and UV, complete with related components. Beyond product supply, Parkway offers a suite of professional services. These include analytical testing, comprehensive project evaluations, process development, detailed project engineering, full installation, expert project management, and ongoing operation and maintenance support. In its ventures division, Parkway holds a stake in the Karinga Lakes potash project located in Australia's Northern Territory and manages a proprietary portfolio of industrial wastewater treatment technologies. The company, initially incorporated in 2010 and headquartered in Sunshine North, Australia, adopted its current name, Parkway Corporate Limited, in September 2021, having previously operated as Parkway Minerals NL.
Greenwing Resources Ltd
―
Celsius Resources
―
Everest Metals Corporation Limited
―
Agrimin Limited
―
Australian Rare Earths Limited
―